GT Biopharma Inc (GTBP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
12,432,200
EV to revenue ratio (TTM)
773.27
EV to ebitda
-0.088
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
0
EBITDA
-6,760,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-158.20%
Return on equity (TTM)
-113.50%
Per Share Metrics
Revenue per share (TTM)
0
EPS
130.25
Diluted EPS (TTM)
130.25
Book value
2
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
0.053
Trailing P/E
0.053
Forward P/E
17.33
PEG ratio
1.049
Price to sales ratio (TTM)
204.96
Price to book ratio (TTM)
3.591
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.908